Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 5 | 2024 | 113 | 2.420 |
Why?
|
| Postural Balance | 3 | 2025 | 11 | 2.210 |
Why?
|
| Ataxia | 4 | 2024 | 38 | 2.200 |
Why?
|
| Tremor | 4 | 2024 | 41 | 2.200 |
Why?
|
| Heterozygote | 3 | 2016 | 48 | 1.060 |
Why?
|
| Cerebral Cortex | 3 | 2025 | 28 | 1.050 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2016 | 65 | 1.040 |
Why?
|
| Parietal Lobe | 1 | 2025 | 6 | 0.940 |
Why?
|
| Huntington Disease | 1 | 2025 | 12 | 0.930 |
Why?
|
| Psychomotor Performance | 1 | 2025 | 34 | 0.920 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 34 | 0.910 |
Why?
|
| Male | 8 | 2025 | 1860 | 0.600 |
Why?
|
| Aged | 5 | 2025 | 956 | 0.590 |
Why?
|
| Middle Aged | 4 | 2025 | 792 | 0.570 |
Why?
|
| Adult | 4 | 2025 | 794 | 0.540 |
Why?
|
| Humans | 7 | 2025 | 2957 | 0.540 |
Why?
|
| Female | 7 | 2025 | 1724 | 0.530 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 97 | 0.510 |
Why?
|
| Gait | 1 | 2016 | 36 | 0.480 |
Why?
|
| Receptors, Estrogen | 5 | 1995 | 5 | 0.430 |
Why?
|
| Hyperkinesis | 1 | 2013 | 8 | 0.400 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 7 | 0.400 |
Why?
|
| Biomechanical Phenomena | 4 | 2022 | 95 | 0.380 |
Why?
|
| Hippocampus | 4 | 1995 | 41 | 0.320 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2025 | 3 | 0.240 |
Why?
|
| Prodromal Symptoms | 1 | 2024 | 5 | 0.210 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 567 | 0.210 |
Why?
|
| Biomarkers | 1 | 2024 | 101 | 0.200 |
Why?
|
| Animals | 7 | 2016 | 1050 | 0.190 |
Why?
|
| Shoes | 1 | 2022 | 3 | 0.180 |
Why?
|
| Walking | 1 | 2022 | 15 | 0.180 |
Why?
|
| Phenotype | 2 | 2016 | 75 | 0.150 |
Why?
|
| Congresses as Topic | 1 | 2016 | 9 | 0.120 |
Why?
|
| Brain Tissue Transplantation | 2 | 1993 | 5 | 0.120 |
Why?
|
| Posture | 1 | 2016 | 8 | 0.120 |
Why?
|
| Disability Evaluation | 1 | 2016 | 23 | 0.120 |
Why?
|
| Computers | 1 | 2015 | 4 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 10 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 7 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 27 | 0.120 |
Why?
|
| Reaction Time | 1 | 2015 | 29 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 24 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2016 | 233 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 28 | 0.120 |
Why?
|
| Animals, Newborn | 3 | 1993 | 12 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 1995 | 59 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1994 | 1 | 0.110 |
Why?
|
| Pituitary-Adrenal System | 1 | 1994 | 1 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 1994 | 1 | 0.110 |
Why?
|
| Sexual Behavior, Animal | 1 | 1994 | 1 | 0.110 |
Why?
|
| Arousal | 1 | 1994 | 6 | 0.110 |
Why?
|
| Rats | 6 | 1995 | 234 | 0.110 |
Why?
|
| Neurons | 2 | 1995 | 55 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 12 | 0.100 |
Why?
|
| Movement | 1 | 2013 | 16 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 142 | 0.100 |
Why?
|
| Young Adult | 1 | 2013 | 187 | 0.100 |
Why?
|
| Child | 1 | 2013 | 197 | 0.100 |
Why?
|
| Adolescent | 1 | 2013 | 247 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1995 | 161 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1993 | 3 | 0.050 |
Why?
|
| Estradiol | 2 | 1993 | 3 | 0.050 |
Why?
|
| Pregnancy | 2 | 1993 | 50 | 0.050 |
Why?
|
| Mechanical Phenomena | 1 | 2022 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 83 | 0.040 |
Why?
|
| Aging | 2 | 1993 | 204 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 1 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 1 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 2 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 5 | 0.030 |
Why?
|
| Sex Differentiation | 1 | 1995 | 1 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 4 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1995 | 5 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 10 | 0.030 |
Why?
|
| Gene Expression | 1 | 1995 | 45 | 0.030 |
Why?
|
| Age Factors | 1 | 1995 | 89 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1994 | 1 | 0.030 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1994 | 3 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1994 | 23 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 1994 | 43 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 6 | 0.030 |
Why?
|
| Cytosol | 2 | 1992 | 23 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 1993 | 1 | 0.030 |
Why?
|
| Preoptic Area | 1 | 1993 | 2 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1993 | 7 | 0.030 |
Why?
|
| Calcium | 1 | 1995 | 231 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 1 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 1990 | 1 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 1990 | 1 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 1990 | 1 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1990 | 9 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 63 | 0.020 |
Why?
|
| Sex Factors | 1 | 1990 | 72 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 1995 | 1 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1995 | 6 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 4 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 119 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 9 | 0.010 |
Why?
|